Notes And Other Explanatory Information [Abstract]

Bavarian Nordic - Filing #5888886

Concept	2024-01-01 to 2024-12-31
Notes and other explanatory information [abstract]
Disclosure of accounting judgements and estimates [text block]	Note 2
Disclosure of allowance for credit losses [text block]	Note 19
Disclosure of auditors' remuneration [text block]	Note 10
Disclosure of authorisation of financial statements [text block]	Note 35
Disclosure of basis of consolidation [text block]	Basis of consolidation
Disclosure of borrowing costs [text block]	DKK thousand
Disclosure of business combinations [text block]	Note 30
Disclosure of cash and cash equivalents [text block]	Cash risks
Disclosure of changes in accounting policies [text block]	Implementation of new and revised standards and
Disclosure of collateral [text block]	Securities (level 1)
Disclosure of commitments and contingent liabilities [text block]	Note 32
Disclosure of cost of sales [text block]	Note 4
Disclosure of credit risk [text block]	Credit risk
Disclosure of debt instruments [text block]	Note 25
Disclosure of deferred taxes [text block]	DKK thousand
Disclosure of depreciation and amortisation expense [text block]	Note 9
Disclosure of derivative financial instruments [text block]	Note 23
Disclosure of earnings per share [text block]	Note 14
Disclosure of effect of changes in foreign exchange rates [text block]	Exchange rate risks
Disclosure of employee benefits [text block]	Note 8
Disclosure of entity's operating segments [text block]	DKK thousand
Disclosure of events after reporting period [text block]	Note 34
Disclosure of fair value of financial instruments [text block]	2024
Disclosure of finance cost [text block]	Note 12
Disclosure of financial instruments at fair value through profit or loss [text block]	Fair value hierarchy for financial instruments measured at fair value
Disclosure of general and administrative expense [text block]	Note 7
Disclosure of impairment of assets [text block]	Note 15
Disclosure of income tax [text block]	Note 13
Disclosure of information about key management personnel [text block]	DKK thousand
Disclosure of interest income [text block]	Note 11
Disclosure of inventories [text block]	Note 18
Disclosure of issued capital [text block]	Transactions on the share capital
Disclosure of leases [text block]	Note 17
Disclosure of liquidity risk [text block]	Policy for managing financial risks
Disclosure of market risk [text block]	Market risks
Disclosure of material accounting policy information [text block]	Note 1
Disclosure of other current liabilities [text block]	Note 22
Disclosure of other provisions, contingent liabilities and contingent assets [text block]	Note 24
Disclosure of prepayments and other assets [text block]	Note 21
Disclosure of property, plant and equipment [text block]	Note 16
Disclosure of provisions [text block]	Key accounting estimates
Disclosure of related party [text block]	Note 33
Disclosure of research and development expense [text block]	Note 6
Disclosure of revenue [text block]	Note 3
Disclosure of revenue from contracts with customers [text block]	Accounting for contract with Biomedical Advanced
Disclosure of share capital, reserves and other equity interest [text block]	The share capital comprises a total of 78,854,857 shares
Disclosure of share-based payment arrangements [text block]	Note 29
Disclosure of treasury shares [text block]	Treasury shares